I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Elalfy, Mohsen S.
157
results:
Search for persons
X
Format
Online (157)
Mediatypes
Articles (Online) (147)
Bookchapter (Online) (1)
OpenAccess-fulltext (9)
Languages
english (150)
german (1)
Sorted by: Relevance
Sorted by: Year
?
1
ALL-019 Iron Status and Overload in Children With Acute Lym..:
Elalfy, Mohsen S.
;
Ramadan, Samah
;
Kamel, Sameh N.
.
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S236 , 2023
Link:
https://doi.org/10.1016/..
?
2
Deferiprone for transfusional iron overload in sickle cell ..:
Elalfy, Mohsen S.
;
Hamdy, Mona
;
El-Beshlawy, Amal
...
Blood Advances. 7 (2023) 4 - p. 611-619 , 2023
Link:
https://doi.org/10.1182/..
?
3
POSTER: ALL-019 Iron Status and Overload in Children With A..:
Elalfy, Mohsen S.
;
Ramadan, Samah
;
Kamel, Sameh N.
.
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S149 , 2023
Link:
https://doi.org/10.1016/..
?
4
Deferiprone versus deferoxamine for transfusional iron over..:
Hamdy, Mona
;
El‐Beshlawy, Amal
;
Veríssimo, Mônica P. A.
...
Pediatric Blood & Cancer. 71 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1002/..
?
5
Efficacy and safety of early‐start deferiprone in infants a..:
Elalfy, Mohsen S.
;
Hamdy, Mona
;
Adly, Amira
...
American Journal of Hematology. 98 (2023) 9 - p. 1415-1424 , 2023
Link:
https://doi.org/10.1002/..
?
6
Deferiprone vs deferoxamine for transfusional iron overload..:
Kwiatkowski, Janet L.
;
Hamdy, Mona
;
El-Beshlawy, Amal
...
Blood Advances. 6 (2022) 4 - p. 1243-1254 , 2022
Link:
https://doi.org/10.1182/..
?
7
Efficacy and safety of a novel combination of two oral chel..:
Elalfy, Mohsen S.
;
Adly, Amira M
;
Wali, Yasser
...
European Journal of Haematology. 95 (2015) 5 - p. 411-420 , 2015
Link:
https://doi.org/10.1111/..
?
8
Role of vitamin C as an adjuvant therapy to different iron ..:
Elalfy, Mohsen S.
;
Saber, Maha M.
;
Adly, Amira Abdel Moneam
...
European Journal of Haematology. 96 (2015) 3 - p. 318-326 , 2015
Link:
https://doi.org/10.1111/..
?
9
Continuation of deferiprone therapy in patients with mild n..:
El‐Beshlawy, Amal M.
;
El‐Alfy, Mohsen S.
;
Sari, Teny T.
..
European Journal of Haematology. 92 (2014) 4 - p. 337-340 , 2014
Link:
https://doi.org/10.1111/..
?
10
Liver fibrosis in young Egyptian beta-thalassemia major pat..:
Elalfy, Mohsen S.
;
Esmat, Gamal
;
Matter, Randa M.
..
Annals of Hepatology. 12 (2013) 1 - p. 54-61 , 2013
Link:
https://doi.org/10.1016/..
?
11
Therapeutic superiority and safety of combined hydroxyurea ..:
Elalfy, Mohsen S.
;
Adly, Amira A. M.
;
Ismail, Eman A.
..
European Journal of Haematology. 91 (2013) 6 - p. 522-533 , 2013
Link:
https://doi.org/10.1111/..
?
12
Pattern of milk feeding and family size as risk factors for..:
Elalfy, Mohsen S.
;
Hamdy, Ahmad M.
;
Abdel Maksoud, Sahar S.
.
Nutrition Research. 32 (2012) 2 - p. 93-99 , 2012
Link:
https://doi.org/10.1016/..
?
13
A new tool for the assessment of satisfaction with iron che..:
Elalfy, Mohsen S.
;
Massoud, Walid
;
Elsherif, Nayera H.
...
Pediatric Blood & Cancer. 58 (2012) 6 - p. 910-915 , 2012
Link:
https://doi.org/10.1002/..
?
14
Achieving treatment goals of reducing or maintaining body i..:
Taher, Ali
;
Elalfy, Mohsen S.
;
Al Zir, Kusai
...
European Journal of Haematology. 87 (2011) 4 - p. 349-354 , 2011
Link:
https://doi.org/10.1111/..
?
15
Importance of optimal dosing ≥30 mg/kg/d during deferasirox..:
Taher, Ali
;
Elalfy, Mohsen S.
;
Al Zir, Kusai
...
European Journal of Haematology. 87 (2011) 4 - p. 355-365 , 2011
Link:
https://doi.org/10.1111/..
1-15